首页> 外文期刊>Journal of Orthopaedic Translation >Percutaneous vertebral augmentation in special Genant IV osteoporotic vertebral compression fractures
【24h】

Percutaneous vertebral augmentation in special Genant IV osteoporotic vertebral compression fractures

机译:Genant IV特殊骨质疏松性椎体压缩性骨折的经皮椎体增大

获取原文
           

摘要

BackgroundPercutaneous vertebral augmentation is widely used for treating osteoporotic vertebral compression fractures (OVCFs). Bony encroachment in the spinal canal can be detected in some severe cases, increasing the difficulty of operation and risks of perioperative complications.PurposeA special type of OVCF has been introduced, and the clinical efficacy of vertebral augmentation has been evaluated in treating this special OVCF.Materials and methodsThe medical history of patients with OVCF treated with vertebral augmentation was reviewed. The vertebral body height and local kyphotic angle were measured and calculated on the lateral plain radiographs. The visual analogue scale and Oswestry Disability Index were assessed preoperatively, two days after operation, and at final follow-up periods. Complications such as cement leakage and recurrent vertebral fractures were also recorded and followed up.ResultsTwenty-nine patients with special Genant IV OVCF accepted vertebral augmentation, and 28 of them were followed up. The mean follow-up duration was 21.9 months, ranging from 17 to 34 months. The lateral plain radiographs revealed significant restoration of vertebral body height and local kyphotic angle. Both visual analogue scale and Oswestry Disability Index scores showed improvement 2 days after surgery and at final follow-up. Four patients experienced asymptomatic cement leakage, and 6 patients suffered OVCF recurrence in other segments.ConclusionDespite a great challenge, vertebral augmentation can be considered as a safe and effective option for treating special the Genant IV OVCF, showing significant restoration of vertebral body height, local kyphotic angle, and daily life function.The translational potential of this articleVertebral augmentation has been proven a safe and effect surgery method for special Genant IV OVCF. While surgery complications related to the commercially available filling material – polymethyl methacrylate (PMMA) is common and inevitable. Hence, this article is aimed to provide practical surgical techniques and suggestions to the modification of PMMA and fabrication of newly developed bone cements.
机译:背景技术经皮椎体增强术被广泛用于治疗骨质疏松性椎体压缩性骨折(OVCF)。在一些严重的情况下,可以发现椎管内的骨侵犯,增加了手术的难度和围手术期并发症的风险。目的引入一种特殊类型的OVCF,并评估椎体隆突的临床疗效。材料和方法回顾了经椎体隆突治疗的OVCF患者的病史。在侧面平片上测量并计算椎体高度和局部后凸角。术前,术后两天以及最后的随访期评估视觉模拟量表和Oswestry残疾指数。结果还记录并随访了并发症,例如骨水泥渗漏和椎骨骨折。结果29例特殊Genant IV OVCF患者接受了椎体隆突,其中28例得到了随访。平均随访时间为21.9个月,范围为17到34个月。侧面X光片显示椎体高度和局部后凸角明显恢复。视觉模拟量表和Oswestry残疾指数评分均显示术后2天和最终随访时均有改善。结论4例患者无症状性骨水泥渗漏,其他部分发生OVCF复发。结论尽管面临巨大挑战,但椎体隆隆可被视为治疗Genant IV OVCF的一种安全有效的方法,可显着恢复椎体高度,局部脊柱后凸角和日常生活功能。本文的椎弓根突矫正术已被证实是一种适用于Genant IV OVCF的安全有效的手术方法。尽管与市售填充材料–聚甲基丙烯酸甲酯(PMMA)有关的手术并发症是常见且不可避免的。因此,本文旨在为PMMA的改性和新开发的骨水泥的制造提供实用的手术技术和建议。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号